“…The current classification of pulmonary' neoplasms may need to be modified in the near future to incorpo rate the newly created data [70][71][72]. At the present time, there appears to be, at least, a need for a 'double standard', as Sobin [73] has suggested, which would permit the evaluation of the biologic significance of the ultrastructural and immunocytochemical findings (as applied to classification of neoplasms) in an effort to derive meaningful clinicopathologic correlations.…”